Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of natural killer cell proliferation. [GOC:mah]
Natural killer (NK) cell proliferation is a tightly regulated process, crucial for maintaining immune homeostasis and effectively responding to viral infections and tumorigenesis. This regulation involves a complex interplay of signaling pathways, both stimulatory and inhibitory, that are triggered by interactions between NK cells and their target cells.
**Stimulatory Signals:**
* **Cytokine Receptor Engagement:** NK cells express receptors for various cytokines, including IL-2, IL-12, IL-15, and IL-18. Engagement of these receptors triggers downstream signaling pathways, leading to enhanced NK cell proliferation, survival, and effector function.
* **Activating Receptor Engagement:** NK cells possess activating receptors, such as NKG2D, NKp46, and DNAM-1, that recognize stress-induced ligands expressed on target cells. Binding of these receptors initiates intracellular signaling cascades, leading to NK cell activation, degranulation, and proliferation.
* **MHC Class I-Independent Recognition:** NK cells can recognize and kill target cells that lack or express low levels of MHC class I molecules, a mechanism known as "missing self" recognition. This involves inhibitory receptors, such as KIRs and LILRB1, that are normally engaged by MHC class I molecules.
**Inhibitory Signals:**
* **MHC Class I-Dependent Recognition:** Inhibitory receptors on NK cells, such as KIRs and LILRB1, interact with MHC class I molecules expressed on target cells. This interaction delivers inhibitory signals that prevent NK cell activation and cytotoxicity, ensuring self-tolerance.
* **Other Inhibitory Receptors:** NK cells express various other inhibitory receptors, including CD94/NKG2A, that can dampen NK cell activation and proliferation.
**Transcriptional Regulation:**
* **Transcription Factors:** The transcription factors T-bet, Eomes, and STAT4 play crucial roles in regulating NK cell proliferation and differentiation. These factors are activated by cytokine signaling pathways, influencing the expression of genes essential for NK cell function.
* **Epigenetic Modifications:** Epigenetic modifications, such as DNA methylation and histone acetylation, can influence the accessibility of genes involved in NK cell proliferation.
**Key Regulatory Pathways:**
* **PI3K/AKT Pathway:** This pathway is activated by activating receptor engagement and cytokine signaling. It promotes NK cell survival, proliferation, and effector function.
* **MAPK Pathway:** This pathway is also activated by activating receptors and cytokines, leading to increased NK cell proliferation and cytokine production.
* **NF-κB Pathway:** This pathway is involved in regulating NK cell survival, cytokine production, and effector function.
**Regulation of NK Cell Proliferation in Specific Contexts:**
* **Viral Infections:** During viral infections, NK cells proliferate and differentiate into effector cells that can eliminate virus-infected cells. This process is regulated by cytokines, such as IL-12 and IL-15, and by interactions with target cells expressing viral ligands.
* **Tumorigenesis:** NK cells play an important role in anti-tumor immunity. Their proliferation and function are influenced by the tumor microenvironment, including factors such as tumor-associated cytokines, chemokines, and inhibitory molecules.
The intricate regulation of NK cell proliferation ensures the appropriate balance between immune surveillance and self-tolerance. Understanding the molecular mechanisms governing this process is crucial for developing novel therapeutic strategies to enhance NK cell function in cancer and infectious disease settings.'
"
Protein | Definition | Taxonomy |
---|---|---|
Tyrosine-protein phosphatase non-receptor type 22 | A tyrosine-protein phosphatase non-receptor type 22 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y2R2] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
lawsone | lawsone : 1,4-Naphthoquinone carrying a hydroxy function at C-2. It is obtained from the leaves of Lawsonia inermis. lawsone: a molluscacide from leaves of Lawsonia inermis L. topical sunscreening agent; structure; powdered leaves of Lawsonia inermis(Lythraceae) used as brown hair dye | ||
1,2-naphthoquinone | 1,2-naphthoquinone : The parent structure of the family of 1,2-naphthoquinones, in which the oxo groups of the quinone moiety are at positions 1 and 2 of the naphthalene ring. It is a metabolite of naphthalene and is found in diesel exhaust particles. naphthalene-1,2-dione: structure given in first source | 1,2-naphthoquinones | aryl hydrocarbon receptor agonist; carcinogenic agent |
1,2-dihydroxynaphthalene | 1,2-dihydroxynaphthalene: RN given refers to parent cpd | naphthalenediol | mouse metabolite |
cefsulodin | cefsulodin : A pyridinium-substituted semi-synthetic, broad-spectrum, cephalosporin antibiotic. Cefsulodin: A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients. | cephalosporin; organosulfonic acid; primary carboxamide | antibacterial drug |
morusin | morusin : An extended flavonoid that is flavone substituted by hydroxy groups at positions 5, 2' and 4', a prenyl group at position 3 and a 2,2-dimethyl pyran group across positions 7 and 8. morusin: from Morus root bark; structure given in first source | extended flavonoid; trihydroxyflavone | antineoplastic agent; plant metabolite |
trans-2,3',4,5'-tetrahydroxystilbene | trans-2,3',4,5'-tetrahydroxystilbene: hydroxystilbene oxyresveratrol | stilbenoid | |
Norartocarpetin | flavones | ||
cudraflavanone a | cudraflavanone A: antineoplastic from Cudrania tricuspidata; structure in first source | ||
3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid | 3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1H-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1H-indole-5-carboxylic acid: an SHP2 inhibitor; structure in first source |